1 suspended, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Suspended 1, Terminated 1 |
Follow pegamotecan: new trials by email Literature Review of pegamotecan trials Research Report on pegamotecan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Pegamotecan (PEG-Camptothecin) in Localized or Metastatic Cancer of the Stomach or Gastroesophageal Junction Pegamotecan - Cancer of Stomach, Gastroesophageal Cancer | Phase 2 | Terminated | Enzon Pharmaceuticals, Inc. | 2003-12-01 | 2012-09-06 | |
| Efficacy and Safety Evaluation of Pegamotecan (PEG-camptothecin) in Advanced or Metastatic Soft Tissue Sarcoma Pegamotecan - Sarcoma, Soft Tissue | Phase 2 | Suspended | Enzon Pharmaceuticals, Inc. | 2003-08-01 | 2012-09-06 |
Neoplasm Metastasis (1) · Neoplasms (1) · Sarcoma (1) · Stomach Neoplasms (1)
Enzon Pharmaceuticals, Inc. (2)
United States (1)